June 17, 2025 11:11 AM EDT
News Briefing

Prothena moves for­ward with lay­offs; Aldeyra re­sub­mits dry eye drug to FDA

ENDPOINTS

Plus, news about Ven­tyx Bio­sciences, Gilead Sci­ences, In­sil­i­co Med­i­cine and En­liv­en Ther­a­peu­tics:

Prothena lays off 91 work­ers: The com­pa­ny pre­vi­ous­ly dis­closed plans …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA un­veils one-year pi­lot to speed some new drugs to mar­ket in just one month

Af­ter a qui­et year, Xaira un­wraps some of its AI re­search, eye­ing a vir­tu­al cell

Lil­ly to bol­ster gene edit­ing pipeline, buy­ing Verve for up to $1.3B

Dyne piv­ots on pri­ma­ry end­point, de­lays fil­ing for DM1 drug

Or­phan drug, PBM changes are ex­clud­ed from Sen­ate ver­sion of Trump tax bill

sponsored

This com­pa­ny has spent a decade in­no­vat­ing NGS-based com­pan­ion di­ag­nos­tics world­wide–what’s next?

A service from the Financial Times